In this educational symposium presented at ISPOR Europe 2022, we discussed the components of the EU joint HTA regulation, shared anticipated impacts at the level of the joint and individual EU member HTA body, and provided critical considerations for health technology developers as they prepare for market authorization and HTA submission in this new and evolving process.